Polymeric Nanoparticles in Gene Therapy: New Avenues of Design and Optimization for Delivery Applications
Top Cited Papers
Open Access
Abstract
The field of polymeric nanoparticles is quickly expanding and playing a pivotal role in a wide spectrum of areas ranging from electronics, photonics, conducting materials, and sensors to medicine, pollution control, and environmental technology. Among the applications of polymers in medicine, gene therapy has emerged as one of the most advanced, with the capability to tackle disorders from the modern era. However, there are several barriers associated with the delivery of genes in the living system that need to be mitigated by polymer engineering. One of the most crucial challenges is the effectiveness of the delivery vehicle or vector. In last few decades, non-viral delivery systems have gained attention because of their low toxicity, potential for targeted delivery, long-term stability, lack of immunogenicity, and relatively low production cost. In 1987, Felgner et al. used the cationic lipid based non-viral gene delivery system for the very first time. This breakthrough opened the opportunity for other non-viral vectors, such as polymers. Cationic polymers have emerged as promising candidates for non-viral gene delivery systems because of their facile synthesis and flexible properties. These polymers can be conjugated with genetic material via electrostatic attraction at physiological pH, thereby facilitating gene delivery. Many factors influence the gene transfection efficiency of cationic polymers, including their structure, molecular weight, and surface charge. Outstanding representatives of polymers that have emerged over the last decade to be used in gene therapy are synthetic polymers such as poly(l-lysine), poly(l-ornithine), linear and branched polyethyleneimine, diethylaminoethyl-dextran, poly(amidoamine) dendrimers, and poly(dimethylaminoethyl methacrylate). Natural polymers, such as chitosan, dextran, gelatin, pullulan, and synthetic analogs, with sophisticated features like guanidinylated bio-reducible polymers were also explored. This review outlines the introduction of polymers in medicine, discusses the methods of polymer synthesis, addressing top down and bottom up techniques. Evaluation of functionalization strategies for therapeutic and formulation stability are also highlighted. The overview of the properties, challenges, and functionalization approaches and, finally, the applications of the polymeric delivery systems in gene therapy marks this review as a unique one-stop summary of developments in this field.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-03689)
This publication has 198 references indexed in Scilit:
- Colloidal stability of polymeric nanoparticles in biological fluidsJournal of Nanoparticle Research, 2012
- String-Like Micellar Nanoparticles Formed by Complexation of PEG-b-PPA and Plasmid DNA and Their Transfection EfficiencyPharmaceutical Research, 2011
- Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccinesJournal of Nanobiotechnology, 2011
- Development of recombinant cationic polymers for gene therapy researchAdvanced Drug Delivery Reviews, 2010
- Ease of Synthesis, Controllable Sizes, and In Vivo Large‐Animal‐Lymph Migration of Polymeric NanoparticlesChemMedChem, 2010
- Functionalized poly(lactic-co-glycolic acid) enhances drug delivery and provides chemical moieties for surface engineering while preserving biocompatibilityActa Biomaterialia, 2009
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- PEG Branched Polymer for Functionalization of Nanomaterials with Ultralong Blood CirculationJournal of the American Chemical Society, 2009
- Factors Affecting the Clearance and Biodistribution of Polymeric NanoparticlesMolecular Pharmaceutics, 2008
- ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivoGene Therapy, 1997